We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

Two sleeves of oral medication.

Study Investigates How Aspirin Helps To Prevent Colorectal Cancer Development

A network of green vessels with parts highlighted in red.

Fibrin Immunotherapy’s Potential for Treating Traumatic Brain Injury

A 3D model of a human brain.

Hidden Brain Region May Unlock New Epilepsy Treatment

Cell Therapy Treatment Effectively Treats Immune-Compromised Children

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

News

Nanogel That Delivers One-Two Punch To Cancer Heads To Clinical Trial

Yale scientists create a nanogel which can be used to deliver multiple drugs to cancer cells.

Liver-On-Chip Tracks Dynamics of Cellular Function

Hebrew University’s liver-on-chip platform is uniquely able to monitor metabolic changes indicating mitochondrial damage occurring at drug concentrations previously regarded as safe.

MorphoSys Initiates Phase 2 Combination Trial

Company has announced that it has initiates Phase 2 combination trial of MOR208 and Lenalidomide in patients with Relapsed or Refractory DLBCL.

FEI Partners with Pharmaceutical Leaders

Company has announced partnership with five pharmaceutical companies for Drug Discovery Research.

SymCel Initiative to Combat Antibiotic Drug Resistance

The innovative Calscreener technology, already firmly established in academic and pre-clinical research, is entering the relm of medical diagnostics.

Aesica Adds Development Capability at Queenborough

Product life cycle services expanded including for high potent and controlled drugs.

EU Project Aims to Cure Type 1 Diabetes

Researchers develop organoids from insulin-producing cells for transplantation.

Gilead Acquires Nimbus Therapeutics’

Nimbus Therapeutics will receive an upfront payment of $400 million, with the potential to receive an additional $800 million in development-related milestones over time.

Fighting Early Stage Alzheimer's

Mouse study suggests possibility of curbing early synapse loss in Alzheimer’s.

Oncology, Drug Development and Toxicology to Fuel Rise of 3D Cell Culture

On the basis of the end user, biotechnology and biopharmaceutical industries dominate the 3D cell culture market.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter